Akili Investor Relations Material
Latest events
Q3 2023
Akili
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Akili Inc
Access all reports
Akili Inc is a prescription digital medicine company combining scientific and clinical rigor with the ingenuity of the tech industry to reinvent our understanding of ADHD. Leveraging decades of neuroscience, educational, and game development expertise, Akili Inc creates interactive, app-based games that make it easy for adults to develop a healthy relationship with the brain's cognitive control system.
Key slides for Akili Inc
Q3 2023
Akili Inc
Status Update
Akili Inc
Latest articles
Companies That Had Their IPO in 2023: Cautious Optimism
The cautiously optimistic market in 2023 saw stocks rebounded upwards, and interest in IPOs picked up from the previous year.
15 Apr 2024
Puig's 2024 IPO: Paco Rabanne, Jean Paul Gaultier, and Beyond
Explore Puig's journey from its 1914 inception to a 2024 IPO, showcasing its growth, strategic acquisitions, and impact in the beauty and fashion industry.
15 Apr 2024
Alphabet's Unstoppable Rise: From Stanford to Global Tech Leader
Discover Alphabet's rise from a university project to a global tech leader, highlighting its growth, diversification, and visionary leadership.
15 Apr 2024
Ticker symbol
Country
🇺🇸 United States